[1]Sidali S, Trépo E, Sutter O, et al. New concepts in the treatment of hepatocellular carcinoma[J]. United European Gastroenterol J, 2022,10:765-774. [2]Sendinc E, Shi Y. RNA m6A methylation across the transcriptome[J]. Mol Cell, 2023,83:428-441. [3]Chauhdary Z, Rehman K, Akash MSH. The composite alliance of FTO locus with obesity-related genetic varia[J]. Clin Exp Pharmacol Physiol, 2021,48:954-965. [4]Benchoula K, Arya A, Parhar IS, et al. FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity[J]. Eur J Pharmacol, 2021,891:173758. doi: 10.1016/j.ejphar.2020.173758. [5]Ma X, Suo Z, Ma X,et al. Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma[J]. J Ethnopharmacol, 2022,296:115433. doi: 10.1016/j.jep.2022.115433. [6]Han X, Guo J, Fan Z. Interactions between m6A modification and miRNAs in malignant tumors[J]. Cell Death Dis, 2021,12:598-602. doi: 10.1038/s41419-021-03868-5. [7]Yang Z, Yu GL, Zhu X,et al. Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders[J]. Genes Dis, 2021;9:51-61. [8]Li M, Wu X, Li G,et al. FTO promotes the stemness of gastric cancer cells[J]. DNA Cell Biol, 2023,42:411-420. [9]Xu D, Shao W, Jiang Y,et al. FTO expression is associated with the occurrence of gastric cancer and prognosis[J]. Oncol Rep, 2017,38:2285-2292. [10]Li Y, Zheng D, Wang F,et al. Expression of demethylase genes, FTO and ALKBH1, is associated with prognosis of gastric cancer[J]. Dig Dis Sci, 2019,64:1503-1513. [11]Saljooghi S, Heidari Z, Saravani M,et al. Association of FOXO1 Rs17592236 polymorphism and tumor size in papillary thyroid carcinoma[J]. Rep Biochem Mol Biol, 2022,11:216-223. [12]Gao H, Zhou L, Zhong Y, et al. Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice[J]. Nat Commun,2022,13:1025-1027.doi: 10.1038/s41467-022-28692-z. [13]Jiang J, Huang Z, Chen X, et al. Trifluoperazine activates FOXO1-related signals to inhibit tumor growth in hepatocellular carcinoma[J]. DNA Cell Biol, 2017,36:813-821. |